SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001140361-24-036444 from Bionano Genomics, Inc. (BNGO)

Bionano Genomics, Inc.
Date: Aug. 8, 2024 · CIK: 0001411690 · Accession: 0001140361-24-036444

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-281138

Date
August 8, 2024
Author
By
Form
CORRESP
Company
Bionano Genomics, Inc.

Letter

BIONANO GENOMICS, INC.

9540 Towne Centre Drive, Suite 100

San Diego, CA 92121

VIA EDGAR

August 8, 2024

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, N.E.

Washington, D.C. 20549

Attn: Abby Adams

Re:

Bionano Genomics, Inc.

Registration Statement on Form S-3

File No. 333-281138

Acceleration Request

Requested Date:

August 12, 2024

Requested Time:

4:30 p.m. Eastern Time

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Bionano Genomics, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-281138) (the “Registration Statement”) to become effective on August 12, 2024, at 4:30 p.m. Eastern Time, or as soon thereafter as is practicable.

Once the Registration Statement has been declared effective, please orally confirm that event with Thomas Coll or Alexander Gefter of Cooley LLP, our outside counsel, at (858) 550-6013 or (310) 883-6438. Thank you for your assistance with this matter.

Sincerely,
BIONANO GENOMICS, INC.

Show Raw Text
CORRESP
1
filename1.htm

    BIONANO GENOMICS, INC.

    9540 Towne Centre Drive, Suite 100

    San Diego, CA 92121

    VIA EDGAR

    August 8, 2024

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    Office of Industrial Applications and Services

    100 F Street, N.E.

    Washington, D.C. 20549

    Attn: Abby Adams

            Re:

            Bionano Genomics, Inc.

            Registration Statement on Form S-3

            File No. 333-281138

            Acceleration Request

            Requested Date:

            August 12, 2024

            Requested Time:

            4:30 p.m. Eastern Time

    Ladies and Gentlemen:

    In accordance with Rule 461 under the Securities Act of 1933, as amended, Bionano Genomics, Inc. hereby requests that the Securities and Exchange Commission
      take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-281138) (the “Registration
        Statement”) to become effective on August 12, 2024, at 4:30 p.m. Eastern Time, or as soon thereafter as is practicable.

    Once the Registration Statement has been declared effective, please orally confirm that event with Thomas Coll or Alexander Gefter of Cooley LLP, our outside
      counsel, at (858) 550-6013 or (310) 883-6438. Thank you for your assistance with this matter.

            Sincerely,

            BIONANO GENOMICS, INC.

            By:

              /s/Jonathan Dixon

            Jonathan Dixon

            General Counsel and Secretary